abstract |
The present invention relates to a novel use of Solute Carrier 6 (SC6), a taurine transporter, in the diagnosis, screening, treatment and prevention of hypoxia-related conditions such as cancer. Compositions comprising the protein are also provided, including antibodies and immunospecific antibodies to the protein, such as vaccines and agents that modulate the expression or activity of the protein. |